Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. (CRL) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CRL · as of Mar 31, 2025
Ownership Breakdown
584
Institutional Holders
▼ 75 vs Q4
$8.04B
Total Inst. Value
▼ $1.74B vs Q4
48.17M
Shares Outstanding
freeFloat 98.80%
53.44M
13F Shares Held
▲ 389,283 vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CRL largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC services-commercial physical & biological research | 6.11M | 12.05% | 12.05% | $919.00B | May 9, 2025 | ▼ 53.4K |
WELLINGTON MANAGEMENT GROUP LLP services-commercial physical & biological research | 4.29M | 8.46% | 8.46% | $644.98B | May 13, 2025 | ▲ 208.6K |
BLACKROCK, INC. services-commercial physical & biological research | 3.67M | 7.24% | 7.24% | $552.53B | May 2, 2025 | ▼ 561.3K |
UBS GROUP AG services-commercial physical & biological research | 2.39M | 4.72% | 4.72% | $360.01B | May 13, 2025 | ▲ 2.06M |
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC services-commercial physical & biological research | 1.95M | 3.85% | 3.85% | $293.56B | May 14, 2025 | ▲ 144.7K |
STATE STREET CORP services-commercial physical & biological research | 1.90M | 3.75% | 3.75% | $286.38B | May 15, 2025 | ▼ 278.8K |
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC services-commercial physical & biological research | 1.77M | 3.50% | 3.50% | $259.07B | Apr 24, 2025 | ▼ 33.4K |
GEODE CAPITAL MANAGEMENT, LLC services-commercial physical & biological research | 1.26M | 2.49% | 2.49% | $189.94B | May 13, 2025 | ▲ 30.5K |
IMPACTIVE CAPITAL LP services-commercial physical & biological research | 1.21M | 2.39% | 2.39% | $182.36B | May 15, 2025 | ▲ 9.2K |
INVESCO LTD. services-commercial physical & biological research | 1.11M | 2.19% | 2.19% | $166.83B | May 12, 2025 | ▲ 74.2K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
26
Increased
+6.47M shares2
New Positions
first time holders22
Decreased
−1.93M shares0
Sold Out
fully exitedNet shares change (top 50)
+4.55M
+6.47M / −1.93M
Net new holders
+6
2 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CRL insider trading · insider activity
Source: SEC Form 4
25
Buy transactions
26
Sell transactions
0.96
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Barg Steven director | Jun 2, 2026 | Award | 422 | $174.79 | $73.8K | 3.3K | Form 4 ↗ |
Coleman Glenn EVP & Chief Financial Officer | May 29, 2026 | Award | 6,640 | $180.71 | $1.20M | 27.8K | Form 4 ↗ |
Mintz Mark EVP, Chief Information Officer | May 29, 2026 | Award | 2,534 | $180.71 | $457.9K | 9.9K | Form 4 ↗ |
Mintz Mark EVP, Chief Information Officer | May 30, 2026 | Tax Withhold | 305 | $180.71 | $55.1K | 9.6K | Form 4 ↗ |
Mintz Mark EVP, Chief Information Officer | May 31, 2026 | Tax Withhold | 64 | $180.71 | $11.6K | 9.5K | Form 4 ↗ |
LaPlume Joseph W EVP, Corp Strategy & Develop | May 29, 2026 | Award | 5,257 | $180.71 | $950.0K | 32.3K | Form 4 ↗ |
LaPlume Joseph W EVP, Corp Strategy & Develop | May 30, 2026 | Tax Withhold | 744 | $180.71 | $134.4K | 31.5K | Form 4 ↗ |
LaPlume Joseph W EVP, Corp Strategy & Develop | May 31, 2026 | Tax Withhold | 235 | $180.71 | $42.5K | 31.3K | Form 4 ↗ |
Knell Michael Gunnar SVP, Finance and CAO | May 29, 2026 | Award | 1,837 | $180.71 | $332.0K | 16.4K | Form 4 ↗ |
Knell Michael Gunnar SVP, Finance and CAO | May 30, 2026 | Tax Withhold | 152 | $180.71 | $27.5K | 16.2K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Charles River Laboratories International, Inc. (CRL) is primarily owned by institutional investors, who hold approximately 100.0% of total shares outstanding. Company insiders own approximately 1.20%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Charles River Laboratories International, Inc. is VANGUARD GROUP INC, holding approximately 6.11 million shares — equal to 12.05% of outstanding shares — as of March 31, 2025.
A total of 584 institutional investors currently hold CRL stock, with a combined institutional value of approximately $8.04 billion as of the most recent 13F filing period.
Frequently asked questions
CRL ownershipCharles River Laboratories International, Inc. (CRL) is primarily owned by institutional investors, who hold approximately 100.0% of shares. The largest shareholder is VANGUARD GROUP INC with a 12.05% stake. Company insiders hold 1.20%. Data sourced from SEC Form 13F as of March 31, 2025.